Advertisement
Canada markets close in 5 hours 4 minutes
  • S&P/TSX

    22,178.27
    +71.19 (+0.32%)
     
  • S&P 500

    5,253.74
    +5.25 (+0.10%)
     
  • DOW

    39,764.84
    +4.76 (+0.01%)
     
  • CAD/USD

    0.7382
    +0.0009 (+0.12%)
     
  • CRUDE OIL

    82.33
    +0.98 (+1.20%)
     
  • Bitcoin CAD

    96,705.24
    +2,216.38 (+2.35%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,232.90
    +20.20 (+0.91%)
     
  • RUSSELL 2000

    2,126.61
    +12.26 (+0.58%)
     
  • 10-Yr Bond

    4.2000
    +0.0040 (+0.10%)
     
  • NASDAQ

    16,404.99
    +5.47 (+0.03%)
     
  • VOLATILITY

    13.00
    +0.22 (+1.72%)
     
  • FTSE

    7,968.27
    +36.29 (+0.46%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6831
    +0.0026 (+0.38%)
     

CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp.'s Technology Has Opportunity for Immediate Impact in Multi-Billion Legal Cannabis Sector

New York, New York--(Newsfile Corp. - October 8, 2018) - CannabisNewsAudio announces the Audio Press Release (APR) titled Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP).

To hear the CannabisNewsAudio version, visit: http://cnw.fm/99vVo

To read the full editorial, visit: http://cnw.fm/z0TDt

The legal global cannabis market started to emerge only recently, thanks to a handful of countries allowing medical marijuana. The market has started to mature through a small but growing number of territories with legal markets for recreational cannabis, as well as the separate management and licensing of industrial hemp. Legal cannabis is now a multibillion-dollar business. Although Lexaria's technology has other profound drug delivery applications, cannabis is where it looks set to have the most immediate impact.

Because patents are among the most valuable assets a company can own, a small investment in research now may pay off in a huge way in years to come. In a sector with such huge growth potential as cannabis, Lexaria's IP portfolio may generate cash flows regardless of whether other companies intend to license the technology or not; by owning core IP, other companies may be forced to pay royalties. If Lexaria's goal of owning hundreds of issued patents becomes a reality, the company's patent portfolio could have huge ramifications on its valuation.

ADVERTISEMENT

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. licenses disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH (Trademarked) delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company's website at www.LexariaBioscience.com

About CannabisNewsWire (CNW)

CannabisNewsWire ("CNW") is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information please visit https://wwwCannabisNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://CNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

CNW Corporate Communications Contact:

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net